Clinuvel Pharmaceuticals Ltd has released a press release.
FDA Grants Marketing Approval for SCENESSE
Filed with ASX ·
Watch Clinuvel Pharmaceuticals' latest callClinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call · Replay · Aug 27Read the transcript of Clinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call6ix hasn’t read this filing yet.
Clinuvel Pharmaceuticals Limited on 6ix
Earlier from Clinuvel Pharmaceuticals
- CLINUVEL renews CEO Employment Agreement
- FDA Clarifies SCENESSE PDUFA Date
- Dividend/Distribution - CUV
- Appendix 4E and Preliminary Financial Report Reissued
- CLINUVEL declares Full Year Dividend
Later from Clinuvel Pharmaceuticals
- TGA Priority Registration Pathway for SCENESSE
- Media Release - SCENESSE to be prescribed in China
- CLINUVEL Corporate Update
- CLINUVEL Full Year Results
- Corporate Presentation - 2020 Full Year Results
Follow Clinuvel Pharmaceuticals into a list and get an email when it puts out news.
Follow Clinuvel Pharmaceuticals